Central versus peripheral effects Retatrutide produces weight loss through both central and peripheral mechanisms
Before treatment is scheduled, a medical evaluation is completed to review your health history, current symptoms, and treatment goals
Adults with a BMI of 27 or higher who also have a weight-related health condition, like diabetes, hyperlipidemia, high blood pressure, or PCOS
Here's how they compare: Wegovy (high-dose semaglutide): About 3% reported hair loss in trials Mounjaro (tirzepatide): About 5.7% on the highest dose reported hair loss Ozempic (lower-dose semaglutide): Hair loss isnt commonly reported (likely because weight loss occurs more moderately) Older GLP-1s like Saxenda (liraglutide): Clinical trials show minimal hair loss reports The key factor seems to be how much and how quickly you lose weight rather than which specific medication you take
About the Company : Chunghwa Chemical Synthesis & Biotech Co
Administered once a week, these injections have demonstrated significant, sustained weight loss results
